Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A Four-Gene Promoter Methylation Marker Panel Consisting of GREM1, NEURL, LAD1, and NEFH Predicts Survival of Clear Cell Renal Cell Cancer Patients

18 Oct 2016

Abstract excerpt

Abstract Purpose: The currently used prognostic models for patients with nonmetastatic clear cell renal cell carcinoma (ccRCC) are based on clinicopathologic features and might be improved by adding molecular markers. Epigenetic alterations occur frequently in ccRCC and are promising biomarkers. The aim of this study is to identify prognostic promoter methylation markers for ccRCC. Experimental Design: We...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Epigenetics and DNA Methylation
Share to Renal and related cancers
Share to Renal cell carcinoma treatment

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 27756787
DOI: 10.1158/1078-0432.ccr-16-1236

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A Four-Gene Promoter Methylation Marker Panel Consisting of GREM1, NEURL, LAD1, and NEFH Predicts Survival of Clear Cell Renal Cell Cancer PatientsPMID 27756787Read ↗

Identification and Comprehensive Validation of a DNA Methylation-Driven Gene-Based Prognostic Model for Clear Cell Renal Cell CarcinomaSemantic proximity Read ↗

Development of a prognostic risk model for clear cell renal cell carcinoma by systematic evaluation of DNA methylation markersSemantic proximity Read ↗

Identification and validation of a DNA methylation-driven gene-based prognostic model for clear cell renal cell carcinomaSemantic proximity Read ↗

Construction and Validation of a Prognostic Nomogram for Clear Cell Renal Cell Carcinoma Based on DNA Methylation-driven Differentially Expressed GenesSemantic proximity Read ↗

Identification of a m6A RNA methylation regulators-based signature for predicting the prognosis of clear cell renal carcinomaSemantic proximity Read ↗

DNA methylation expression patterns predict outcome of clear cell renal cell carcinomaSemantic proximity Read ↗

DNA methylation associates with survival in non-metastatic clear cell renal cell carcinomaSemantic proximity Read ↗

Prognostic Value of an m5C RNA Methylation Regulator-Related Signature for Clear Cell Renal Cell CarcinomaSemantic proximity Read ↗

The Role of Epigenetics in the Progression of Clear Cell Renal Cell Carcinoma and the Basis for Future Epigenetic TreatmentsSemantic proximity Read ↗

A large‐scale transcriptome analysis identified ELANE and PRTN3 as novel methylation prognostic signatures for clear cell renal cell carcinomaSemantic proximity Read ↗

N6-methyladenosine Methylation Related Immune Biomarkers Correlates With Clinicopathological Characteristics and Prognosis in Clear Cell Renal Cell CarcinomaSemantic proximity Read ↗

A CpG-methylation-based assay to predict survival in clear cell renal cell carcinomaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.